Estrogens have been demonstrated to promote the pathological progression of SLE by inhibiting activation-induced apoptosis of SLE T cells through downregulating the Fas-L expression (34) and enhancing autoantibody levels in autoimmune diseases (35). This evidence concerns the gene FASLG and autoimmune disease.